Bioethics

  • Read more: Twitter Round-Up (1/27-2/7)

    Twitter Round-Up (1/27-2/7)

    By Casey Thomson Even the surprisingly resurrected Richard III (on the Twitter-sphere, anyway) appreciates bioethics concerns. Read on to find out more about Richard III’s eagerness for patient confidentiality and other updates in this week’s (extended) Twitter round-up: Stephen Latham (@StephenLatham) included a link to his blog post challenging Andrew Francis’ recent claim that penicillin…

  • Read more: India Releases New Rules on Clinical Trial Injury

    India Releases New Rules on Clinical Trial Injury

    By Holly Fernandez Lynch Last week, the Indian government issued revised rules governing “compensation in case of injury or death during clinical trial.”  You’ve really got to read the whole thing, but some of the provisions are pretty remarkable: “In the case of an injury occurring to the clinical trial subject, he or she shall…

  • Read more: Did Matt Lauer Err by Calling a Negative Test for Down Syndrome “Good News” on the Today Show?

    Did Matt Lauer Err by Calling a Negative Test for Down Syndrome “Good News” on the Today Show?

    By I. Glenn Cohen A new non-invasive genetic test (using blood draw), MaterniT21 Plus, claims it can detect Down Syndrome at 10 weeks of pregnancy. Matt Lauer, inadvertantly no doubt, stepped into the controversy of genetic testing and abortion during a Today Show segment with two parents who had undergone the testing and had a…

  • Read more: Are You Ready for Some . . . Research? Uncertain Diagnoses, Research Data Privacy, & Preference Heterogeneity

    Are You Ready for Some . . . Research? Uncertain Diagnoses, Research Data Privacy, & Preference Heterogeneity

    By Michelle Meyer As most readers are probably aware, the past few years have seen considerable media and clinical interest in chronic traumatic encephalopathy (CTE), a progressive, neurodegenerative condition linked to, and thought to result from, concussions, blasts, and other forms of brain injury (including, importantly, repeated but milder sub-concussion-level injuries) that can lead to…

  • Read more: Humane Transport of Research Animals

    Humane Transport of Research Animals

    By Suzanne M. Rivera, Ph.D. For some time, animal rights activists in the US and abroad have been trying to pressure commercial airlines out of their long-standing practice of transporting research animals.  Last week, a coalition of more than 150 leading research organizations and institutions sent a letter to the CEOs of the targeted airlines,…

  • Read more: Finasteride as an FDA-Approved Baldness Remedy: Is It Effective?

    Finasteride as an FDA-Approved Baldness Remedy: Is It Effective?

    By Jonathan J. Darrow Questionable baldness remedies have been peddled since the beginning of medicine. According to Pliny (23-79 A.D.), ashes of seahorse could cure baldness.  Almost 2000 years later, the British Medical Association warned the public of the increasing “number of preparations put forward for the cure of baldness,” particularly those which “are not…

  • Read more: No Access to Medicines without Access to Research

    No Access to Medicines without Access to Research

    By Adriana Benedict In December, I wrote a blog post noting that access to biomedical research is critical not only for informed patient care, but also for the sustainable development of pharmaceutical R&D responsive to local needs, especially in developing countries.  In recent years, open access issues have taken on an increasingly important role in…

  • Read more: Twitter Round-Up (1/20-1/26)

    Twitter Round-Up (1/20-1/26)

    By Casey Thomson Though simply the consequence of bad translation, the story of the Harvard geneticist George Church looking for a woman to act as surrogate for a Neanderthal clone shocked the internet bioethics world. A look at the problems with this hypothetical situation is just one of the components of this week’s Twitter Round-Up….